• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cambridge Heart prepares to shutter operations

Cambridge Heart prepares to shutter operations

February 13, 2014 By Arezu Sarvestani

Cambridge Heart winds down, prepares to close

Shares of troubled Cambridge Heart (NSDQ:CAMH) continued to spiral as the company announced that it’s winding down its business operations.

CAMH shares have been below 1¢ apiece since February 12, and were down to 0.5¢ as of yesterday’s close.

The company has already auctioned off its assets, raising about $4 million in secured notes issued to Cambridge Heart’s creditors.

"A collateral agent for the Secured Creditors held a public auction … for the sale of all of the company’s assets, which secured approximately $4.03 million in notes issued to the Secured Creditors," according to a Cambridge Heart SEC filing. "The Secured Creditors made a credit bid of $1.5 million and, at the conclusion of the public auction, were deemed the highest bidder for the assets."

The creditors agreed to cancel Cambridge Heart’s $1.5 million outstanding debt, assigning the assets to newly formed Cambridge Cardiac Technologies. The creditors further agreed to fund some of the Cambridge Heart’s last act and to pay all debts incurred since the start of the year.

Cambridge Heart has had a tough road, posting declining sales and persistent losses in recent quarters. The company attempted a turnaround last year, restructuring its operations to reduce its cash burn, including reductions in personnel and overhead costs, and restructured managerial compensation, but couldn’t keep the ship afloat. The company determined late last year that its existing resources weren’t enough to fund operations and that it wouldn’t be able to raise enough cash to keep going.

The company developed non-invasive diagnostics for identifying patients at risk of sudden cardiac arrest, including its Microvolt T-Wave Alternans system and Analytic Spectral Method.

Filed Under: Business/Financial News, News Well, Wall Street Beat Tagged With: Cambridge Heart Inc.

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy